A detailed history of Xr Securities LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Xr Securities LLC holds 1,789 shares of MRK stock, worth $177,772. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,789
Previous 1,864 4.02%
Holding current value
$177,772
Previous $230,000 11.74%
% of portfolio
0.06%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$111.15 - $128.97 $8,336 - $9,672
-75 Reduced 4.02%
1,789 $203,000
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $230,763 - $247,837
1,864 New
1,864 $230,000
Q4 2022

Jan 03, 2023

BUY
$87.44 - $112.11 $561,539 - $719,970
6,422 New
6,422 $713,000
Q2 2022

Jul 14, 2022

SELL
$83.49 - $94.64 $424,797 - $481,528
-5,088 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$73.51 - $82.4 $10,438 - $11,700
-142 Reduced 2.72%
5,088 $417,000
Q1 2021

Apr 29, 2021

SELL
$68.86 - $81.11 $263,182 - $310,002
-3,822 Reduced 42.22%
5,230 $403,000
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $140,382 - $155,795
1,956 Added 27.56%
9,052 $740,000
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $33,516 - $37,991
-458 Reduced 6.06%
7,096 $589,000
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $28,379 - $32,292
-403 Reduced 5.06%
7,554 $584,000
Q1 2020

Apr 09, 2020

BUY
$63.36 - $87.82 $342,840 - $475,194
5,411 Added 212.53%
7,957 $612,000
Q4 2019

Jan 06, 2020

BUY
$77.58 - $87.54 $197,518 - $222,876
2,546 New
2,546 $232,000
Q2 2019

Jul 10, 2019

SELL
$69.84 - $81.59 $641,759 - $749,730
-9,189 Closed
0 $0
Q1 2019

Apr 08, 2019

BUY
$69.58 - $79.36 $639,370 - $729,239
9,189 New
9,189 $764,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.